USANA HEALTH SCIENCES INC
USNACIK 0000896264
Revenue (TTM)
$949.28M
+8.3% YoY
Q1 May 2026
Net Income (TTM)
$20.05M
−74.4% YoY
Q1 May 2026
EPS Diluted (TTM)
$1.06
−73.5% YoY
Q1 May 2026
Gross Margin
77.8%
Q1 May 2026
Operating Margin
5.0%
Q1 May 2026
Net Margin
2.1%
Q1 May 2026
Free Cash Flow (TTM)
$45M
Q1 May 2026
Cash
$162.75M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
18.46M sh
Q1 May 2026